Treatment successfully delivers drug across the blood-brain barrier directly to brain tumor in mice
- Glioblastoma currently has no cure. New treatments urgently needed
- Powerful drug is 1,400 times more potent than current treatment against the brain tumor
- Scientists applying to FDA for approval to test this novel treatment in patients with recurrent glioblastoma
One of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can’t be used in patients because of two problems. First, it can’t reach its target because it’s blocked by the blood-brain barrier, a microscopic structure that protects the brain from toxins in the blood. And the conventional formulation for this drug is toxic to the brain.
But now Northwestern Medicine scientists have used a novel technology for opening the blood-brain barrier with an implantable ultrasound, and have delivered the powerful drug to the tumor in mice. In a new paper, they report on their findings of extensive preclinical research.
The scientists also discovered brain toxicity for the conventional formulation for this drug – paclitaxel -to the brain was caused by the solution required to dissolve the drug (cremophor.) Scientists tested a new formulation of the drug that uses albumin as opposed to cremophor, and it was not harmful to the brain.
Opening of the blood-brain barrier with an ultrasound increased the concentrations of this paclitaxel in the brain by five-fold. The study also showed that the brain tumor-bearing mice live much longer when treated with the powerful cancer-fighting drug paclitaxel, and survival was even further extended when treated in combination with ultrasound to open the blood-brain barrier.
The study will be published Dec. 12 in Clinical Cancer Research, a journal of the American Association for Cancer Research.
In the laboratory, paclitaxel is much more potent than the currently used chemotherapy temozolomide. When paclitaxel was tested against the brain tumor in a dish outside an organism, a 1,400-fold lesser drug concentration was necessary to kill same number of tumor cells, compared to the conventional chemotherapy used for this cancer.
The scientists are now applying to the U.S. Food & Drug Administration to launch a clinical trial to test this concept of a new formulation of paclitaxel in combination with the novel ultrasound technology to open the blood-brain barrier in patients. The planned trial aims to determine if the treatment is safe, and if it prolongs survival of patients with brain cancer.
“Glioblastoma currently has no cure, and when the tumor recurs there are not many treatment options,” said the principal investigator for this study, Dr. Adam Sonabend, an assistant professor of neurological surgery at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician. “We urgently need effective new treatments.”
The ultrasound technology may have broader benefits. “This ultrasound technology now will enable us to use many agents established in other cancers for patients with brain tumors,” said co-investigator Roger Stupp, chief of neuro-oncology and the Paul C. Bucy Professor of Neurological Surgery at Feinberg.
Other clinical trials are testing ultrasound-based opening of the blood brain barrier with various chemotherapy agents, but none are using such a potent drug as paclitaxel.
How does it work?
The tiny ultrasound would be implanted during surgery into a window in the skull that does not contain bone. It is used in combination with microscopic gas bubbles injected into the blood at the same time the ultrasound begins. When the bubbles hit the sound waves, these vibrate and mechanically disrupt the blood-brain barrier. The opening is immediate, allowing penetration of the drug molecules. The blood-brain barrier opening is reversible and lasts for several hours after the sonication. The ultrasound emitter remains in the skull for repeated delivery of the drug.
Go deeper with Bing News on:
- Hall of Famer Westphal battling brain canceron August 9, 2020 at 3:27 pm
Star who won an NBA championship with the Boston Celtics in 1973-74 and was named the Comeback Player of the Year in 1982-83.
- Report: Former Kings coach Paul Westphal diagnosed with aggressive brain canceron August 9, 2020 at 12:53 pm
Basketball Hall of Famer and former Kings coach Paul Westphal has reportedly been diagnosed with brain cancer. New York Daily News columnist Mike Lupica shared the sad news Sunday on Twitter, saying ...
- Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBMon August 8, 2020 at 9:55 pm
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.
- Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastomaon August 7, 2020 at 8:01 am
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed. In vivo experiments demonstrated that ...
- NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathwayson August 7, 2020 at 3:59 am
Glioblastoma (GBM) is the most malignant brain tumor characterized by intrinsic or acquired resistance to chemotherapy. GBM tumors show nuclear factor-κB (NF-κB) activity that has been ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Global Healthcare Ultrasound Equipment Market 2020 Comprehensive Analysis, Future Estimations, Growth Drivers and Forecast to 2025on August 9, 2020 at 3:18 pm
The latest report entitled Global Healthcare Ultrasound Equipment Market 2020 by Manufacturers, Type and Application, Forecast to 2025 is well documented to present a crucial analytical review of the ...
- Global Ultrasound Probe Disinfection Market 2020 Comprehensive Analysis, Future Estimations, Growth Drivers and Forecast to 2025on August 9, 2020 at 2:14 pm
The most recent report titled Global Ultrasound Probe Disinfection Market 2020 by Manufacturers, Type and Application, Forecast to 2025 issued by MarketsandResearch.biz fetches a scheduled analysis of ...
- Ultrasound purchased by Knights of Columbus for Bangor Pregnancy Resource Center to be dedicated on Tuesdayon August 8, 2020 at 10:01 am
A baby bottle drive held by Knights of Columbus Pine Cone Council #114 in Bangor will allow future mothers to see the baby they are carrying, ...
- COVID-19 Impacts: Point-of-care Ultrasound Systems Market will Accelerate at a CAGR of over 6% through 2020-2024 | Increase in Number of Product Launches to Boost Growth ...on August 6, 2020 at 3:30 pm
Technavio has been monitoring the point-of-care ultrasound systems market and it is poised to grow by USD 853.28 million during 2020-2024, progressing at a CAGR of over 6% during the forecast period.
- Targeted ultrasound for noninvasive diagnosis of brain canceron August 6, 2020 at 12:39 pm
Brain tumors are typically diagnosed using MRI imaging, as taking a sample for a tissue biopsy is risky and may not be possible due to tumor location or a patient's poor health conditions. Researchers ...